Ther­mo Fish­er plat­form seeks to ex­pe­dite donor cell cul­ti­va­tion for al­lo­gene­ic cell ther­a­pies

One of the world’s lead­ing CD­MOs has launched a new tech­nol­o­gy it says will ex­pe­dite a quick­ly-grow­ing sect of biotech drug de­vel­op­ment: off-the-shelf, al­lo­gene­ic cell …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER